SCHEMBL19081946

SCHEMBL19081946

c1cc(-c2ccc3sc4ccc5oc6c7ccccc7ccc6c5c4c3c2)cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 14/20 0.33
CYP1B1 Q16678 14/20 0.33
CYP1A2 P05177 13/20 0.33
PRKDC P78527 3/20 0.33
KDM4E B2RXH2 1/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
CYP2B6 P20813 1/20 0.33
TACR2 P21452 1/20 0.33
TBXAS1 P24557 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082054 0.96 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081953 0.94 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081908 0.93 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081945 0.92 AHR (0.33) CYP1A1CYP1A2ALDH1A1TP53CYP3A4
SCHEMBL19081837 0.92 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19082035 0.92 ARSA (0.34) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL19081977 0.92 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19076826 0.91 CYP1A1 (0.34) CYP1A1CYP1B1
SCHEMBL19082060 0.90 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19076693 0.90 BRDT (0.32) CYP1A1CYP1B1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.